The Synthetic Chemistry Core facility will provide four basic services to this Program Project Grant (PPG). First, it will assist in the selection, prioritization and validation of primary hits identified from the efforts of the HTS Core for further chemical development. Second, the Core will provide synthetic servicesto include structure-activity relationship (SAR) studies, scale-up of small molecules of interest for further pre-clinical evaluation, synthesis of labeled compounds (isotopes, radioisotopes, and affinity labels), in addition to general synthetic services for intermediates and reagents not commerciallyavailable. A third service that will encompass the Synthetic Chemistry Core will be to provide analytical chemistry support to assist in compound identification, stability and solubility studies, metabolite identification (in collaboration with the Preclinical Pharmacology Core) and compound purity analysis. Finally, a continuous goal of the Core will be to establish a UTSW Compound Repository for the characterization, collection and submission of drug-like intermediates and analogs synthesized by the Core for inclusion into the current HTS screening library to futher enhance our library diversity.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA095471-08
Application #
7918978
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2009-08-01
Budget End
2010-07-31
Support Year
8
Fiscal Year
2009
Total Cost
$478,235
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Type
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Qi, Chen; Wang, Xin; Shen, Zhirong et al. (2018) Anti-mitotic chemotherapeutics promote apoptosis through TL1A-activated death receptor 3 in cancer cells. Cell Res 28:544-555
Zhang, Lu; Theodoropoulos, Panayotis C; Eskiocak, Ugur et al. (2016) Selective targeting of mutant adenomatous polyposis coli (APC) in colorectal cancer. Sci Transl Med 8:361ra140
Guo, Yirui; Scheuermann, Thomas H; Partch, Carrie L et al. (2015) Coiled-coil coactivators play a structural role mediating interactions in hypoxia-inducible factor heterodimerization. J Biol Chem 290:7707-21
Scheuermann, Thomas H; Stroud, Daniel; Sleet, Christopher E et al. (2015) Isoform-Selective and Stereoselective Inhibition of Hypoxia Inducible Factor-2. J Med Chem 58:5930-41
Rose, Tristan E; Lawson, Kenneth V; Harran, Patrick G (2015) Large ring-forming alkylations provide facile access to composite macrocycles. Chem Sci 6:2219-2223
Zhang, Yongyou; Desai, Amar; Yang, Sung Yeun et al. (2015) TISSUE REGENERATION. Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration. Science 348:aaa2340
Iscla, Irene; Wray, Robin; Wei, Shuguang et al. (2014) Streptomycin potency is dependent on MscL channel expression. Nat Commun 5:4891
Kilgore, Jessica A; Du, Xinlin; Melito, Lisa et al. (2013) Identification of DNMT1 selective antagonists using a novel scintillation proximity assay. J Biol Chem 288:19673-84
Lawson, Kenneth V; Rose, Tristan E; Harran, Patrick G (2013) Template-constrained macrocyclic peptides prepared from native, unprotected precursors. Proc Natl Acad Sci U S A 110:E3753-60
Wang, Gelin; Wang, Xiaoming; Yu, Hong et al. (2013) Small-molecule activation of the TRAIL receptor DR5 in human cancer cells. Nat Chem Biol 9:84-9

Showing the most recent 10 out of 67 publications